The role of IL-12 in the induction of an immune response to a tumor/self peptide: prevention and reversion of anergy.

Belladonna, M L; Grohmann, U; Bianchi, R; Ayroldi, E; Surace, D; Puccetti, P; Fioretti, M C

Belladonna, M L; Grohmann, U; Bianchi, R; Ayroldi, E; Surace, D; Puccetti, P; Fioretti, M C.

Affiliation

Belladonna ML; Department of Experimental Medicine, University of Perugia, Italy. spharmpg@tin.it

J Chemother ; 10(2): 157-9, 1998 Apr.

Article in En | MEDLINE | ID: mdl-9603645

Subject(s)

Antigens, Neoplasm/immunology; Antigens, Neoplasm/pharmacology; Asthenia/prevention & control; Interleukin-2/pharmacology; Major Histocompatibility Complex/immunology; Animals; Antigen-Antibody Complex; Asthenia/immunology; Clonal Anergy; Dendrites/immunology; Dendrites/metabolism; Epitopes/immunology; Hybridomas; Hypersensitivity, Delayed/etiology; Immunity, Cellular; Interleukin-2/immunology; Mice; T-Lymphocytes, Cytotoxic/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Asthenia / Interleukin-2 / Major Histocompatibility Complex / Antigens, Neoplasm Type of study: Etiology_studies Limits: Animals Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 1998 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links